• P68 Cost-Effectiveness of Ofatumumab in Comparison with Teriflunomide for Relapsing Multiple Sclerosis Treatment in China: From Both Healthcare System and Societal Perspectives

    Jul 1, 2022, 00:00

  • EE87 Economic Evauation of Adalimumab Biosimilars and JAK Inhibitors for the Treatment of Moderate-to-Severe Rheumatoid Arthritis

    Jul 1, 2022, 00:00

  • CO45 Impact of Smoking Status on the Combination of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors and Antiangiogenic Agents in Advanced Non-Small-Cell Lung Cancer Harbored Susceptible EGFR Mutation: A Systematic Review ...

    Jul 1, 2022, 00:00

  • EE423 Lower out-of-Pocket Costs Associated with Pegfilgrastim Biosimilars

    Jul 1, 2022, 00:00

  • MSR48 Estimating Event-Specific Probabilities and Conditional Time-to-Event Distributions from Censored Competing Risks Data

    Jul 1, 2022, 00:00

  • HPR35 The Impact of Biosimilar Trastuzumab on Drug Spending in Australia

    Jul 1, 2022, 00:00

  • EE249 Cost-Utility Analysis of Benralizumab in Severe Eosinophilic Asthma in Costa Rica

    Jul 1, 2022, 00:00

  • MSR9 Moving from Static to Dynamic Economic Assessments: The Process of Migrating Economic Models to a Web Environment

    Jul 1, 2022, 00:00

  • EPH96 Infant Immunization Coverage in a Colombian Poor Municipality in the Post-Conflict Era

    Jul 1, 2022, 00:00

  • EE300 Economic Burden of Transfusion-Dependent Chinese Adult -Thalassemia Patients from Social Perspective

    Jul 1, 2022, 00:00

  • EPH148 Disease Burden Related to Eosinophilic Granulomatosis with Polyangiitis (EGPA): A Targeted Literature Analysis

    Jul 1, 2022, 00:00

  • CO18 Real-World Evidence of the Effect of Continuous Subcutaneous Insulin Infusion Vs Multiple Daily Injections on HBA1C in 25,000 Adults with Type 1 Diabetes: A Quasi-Experimental Study

    Jul 1, 2022, 00:00

  • CO9 Updated Evidence on the Use of Solid Oral Dosage Forms in Adults with Neurological Disorders and Swallowing Difficulties: A Scoping Review

    Jul 1, 2022, 00:00

  • CO66 Reduction in Migraine-Associated Burden over 24 Weeks of Treatment with Eptinezumab in Patients with Chronic Migraine

    Jul 1, 2022, 00:00

  • P11 Racial Disparity in Treatments for Tibial Fracture Using Propensity-Score Matched Cohorts in a Medicaid Database

    Jul 1, 2022, 00:00

  • MSR23 A Machine Learning Approach to Score Employer Groups Based on How Well They Manage Their Specialty Drug Spend

    Jul 1, 2022, 00:00

  • EE371 Cost Analysis of Birth Outcomes in the Helping Appalachian Parents and Infants Public Health Initiative

    Jul 1, 2022, 00:00

  • EE275 Number Needed to Treat Analysis of Nivolumab Versus Surveillance for the Adjuvant Treatment of Patients with Resected Esophageal Cancer (EC) or Gastroesophageal Junction Cancer (GEJC)

    Jul 1, 2022, 00:00

  • EE61 Economic Burden of Gastroesophageal Reflux Disease, Barrett's Esophagus, and Esophageal Neoplasia in the United States

    Jul 1, 2022, 00:00

  • EE501 Economic Burden of Gastrointestinal Malignancies Among Medicare Beneficiaries in United States

    Jul 1, 2022, 00:00

  • MSR49 Assessing the Impact of COVID-19 on the Healthcare Resource Utilization and Treatment in High Incidence Oncological Conditions

    Jul 1, 2022, 00:00

  • EE303 Estimating Recurrences Prevented and Costs Avoided with Atezolizumab in Early Non-Small Cell Lung Cancer in the United States

    Jul 1, 2022, 00:00

  • HSD85 Real-World Usage Patterns and Costs of IVIG Treatment in Adults with Generalized Myasthenia Gravis in the United States

    Jul 1, 2022, 00:00

  • HSD12 Assessing the Changes of Spa Hotel Demand in Hungary between 2012 and 2019

    Jul 1, 2022, 00:00

  • EPH14 Epidemiological Disease Burden of Endometriosis Based on Real-World Health Insurance Claims Data in Hungary in 2019

    Jul 1, 2022, 00:00

  • EE177 Economic Impact of Contrast-Induced Nephropathy in Percutaneous Coronary Intervention: A Medicare Payer Perspective

    Jul 1, 2022, 00:00

  • EE360 Decreasing the Economic Impact of Non-Neonatal Circumcision in the Florida Medicaid Population

    Jul 1, 2022, 00:00

  • CO41 Health Outcomes and Resource Utilization in a Real-World Cohort of Hospitalized Crohn's Disease Patients

    Jul 1, 2022, 00:00

  • HTA36 Benefits of Mobile Telephony in Health Care for Rural Health Service Users

    Jul 1, 2022, 00:00

  • EE437 Healthcare Resource Utilization and Costs in Patients with Multiple Myeloma Who Received 1 to 3 Prior Lines of Therapy, Including a Proteasome Inhibitor, an Immunomodulatory Drug, and Exposed to (AND DISCONTINUED) Lenalidomide in the ...

    Jul 1, 2022, 00:00

  • EE130 Digital Remote Monitoring of Intravenous Infusions Frees Capacity and Saves Materials: Economic Evaluation Study in Finland

    Jul 1, 2022, 00:00

  • CO94 Changes in Demographic and Clinical Characteristics of Patients with Type 2 Diabetes (T2DM) Initiating Subcutaneous Semaglutide

    Jul 1, 2022, 00:00

  • EE322 Direct Medical and Indirect Absenteeism Costs Among Working Adult ADHD Patients in the United States

    Jul 1, 2022, 00:00

  • HSD11 Microbiological Examination of Nurses' Hand Hygiene

    Jul 1, 2022, 00:00

  • HTA44 Predictors for Recommendations of Cancer Drugs in Decision Making: A Systematic Literature Review

    Jul 1, 2022, 00:00

  • EE450 Treatments and Diagnostics for COVID-19: A Living Systematic Review of Economic Evaluations

    Jul 1, 2022, 00:00

  • EE500 Comparison of Healthcare Resource Utilization and Costs in Patients with and without Bullous Pemphigoid: A Retrospective Analysis of US Health Insurance Claims Data

    Jul 1, 2022, 00:00

  • EE181 An Economic Model to Estimate Costs of Cytokine Release Syndrome (CRS) and Neurological Events (NE) Among Patients Treated with Lisocabtagene Maraleucel (LISO-CEL) or Axicabtagene Ciloleucel (AXI-CEL) for Second-LINE (2L) Treatment of ...

    Jul 1, 2022, 00:00

  • EE12 A Probabilistic Cost-Effectiveness Analysis of Venetoclax and Obinutuzumab As a First-Line, 12-Month, Fixed Duration Therapy in Chronic Lymphocytic Leukemia (CLL) in Canada

    Jul 1, 2022, 00:00

  • EE302 Households Out-of-Pocket Healthcare Expenditures Based on Number of Chronic Conditions in Riyadh, Saudi Arabia: A Quantile Regression Approach

    Jul 1, 2022, 00:00

  • HTA8 The Relationship between ICER's Evidence Rating Matrix and Incremental Quality-Adjusted Life Years

    Jul 1, 2022, 00:00

  • Clinical Trial Methods and Applications in HEOR

    Jul 1, 2022, 00:00

  • EE191 Medical Cost Related to Diabetes Among Middle-Aged and Elderly Individuals Living in China

    Jul 1, 2022, 00:00

  • HTA11 Access Barrier or Opportunity? Evolving Trends in NRDL Listings in China

    Jul 1, 2022, 00:00

  • EPH132 In-Hospital Mortality Among Hospitalized COVID-19 Patients in the US: How Did It Change in 2021 from ALPHA to DELTA Variant?

    Jul 1, 2022, 00:00

  • HTA42 The Budget Impact Analysis of Acute Stroke Centre Expansion in Ministry of Health Malaysia

    Jul 1, 2022, 00:00

  • EE155 The Impact of Value-Based Pricing (VBP) Vs International Reference Pricing (IRP) on Innovative Drugs in the US

    Jul 1, 2022, 00:00

  • EPH101 Factors Associated with Biologic Disease-Modifying Antirheumatic Drugs Utilization in Rheumatoid Arthritis Patients

    Jul 1, 2022, 00:00

  • P6 Development of Subjective Financial Distress Questionnaire (SFDQ) for Measuring Financial Toxicity Among Cancer Patients Undergoing Radiation Therapy

    Jul 1, 2022, 00:00

  • EPH129 Blue Cross and Blue Shield of Louisiana's COVID-19 Outbreak Simulation- Deterministic SEIR Modeling

    Jul 1, 2022, 00:00

  • HSD105 Real-World Treatment Patterns Among Patients with Mycosis Fungoides and Sézary Syndrome in the United States between 2018 and 2020

    Jul 1, 2022, 00:00

  • MSR39 An Approach to Quantifying and Appending Missing Prescription Utilization for Asthma Patients in Health Plan Claims Data Utilizing Point-of-Sale Data

    Jul 1, 2022, 00:00

  • EE400 Cost-Effectiveness Analysis of Fampridine for Multiple Sclerosis Treatment in China

    Jul 1, 2022, 00:00

  • EE319 Setting a Value-Based Price for Xanomeline-Trospium As Treatment for Markedly Ill Schizophrenia

    Jul 1, 2022, 00:00

  • EE224 Comparative Economic Outcomes in Patients with Focal Seizure Initiating Eslicarbazepine Acetate Versus Brivaracetam after Switching from Generic Antiseizure Drug

    Jul 1, 2022, 00:00

  • EE478 Using Real World Evidence to Generate Cost-Effectiveness Analysis of Fibrinolytic Therapy in Patients with ST-Segment Elevation Myocardial Infarction in a Limited Resource Country

    Jul 1, 2022, 00:00

  • EE202 Direct and Indirect Economic Burden of Adults with Glaucoma in the United States: A Cross-Sectional Analysis of the Medical Expenditure Panel Survey Data

    Jul 1, 2022, 00:00

  • EE359 US Cost-Effectiveness of Chimeric Antigen Receptor T-Cell (CAR T) Therapy for Patients with Relapsed or Refractory Large B-Cell Lymphoma (R/R LBCL), Considering Infusion Setting and Payor Claims Data

    Jul 1, 2022, 00:00

  • EE410 Cost-Effectiveness Analysis of Remdesivir for the Treatment of COVID-19 Hospitalized Adults in Three Countries of LATAM: Argentina, Chile, and Colombia

    Jul 1, 2022, 00:00

  • EPH18 Real-World Biomarker Positivity Rates Among Patients with Advanced Non-Small Cell Lung Cancer in the United States

    Jul 1, 2022, 00:00

  • EE47 Short-Term Cost-Effectiveness of Using Mobile Stroke Unit VS. Standard Ambulance for Patients with Suspected Stroke

    Jul 1, 2022, 00:00

  • EE409 Targeted Literature Review (TLR) of the Economic Burden and Cost-Effectiveness of Treatments for Advanced Non-Small Cell Lung Cancer (ANSCLC)

    Jul 1, 2022, 00:00

  • EE376 Indirect Costs of Diabetes Mellitus in Colombia, 1998-2019

    Jul 1, 2022, 00:00

  • HTA14 A Systematic Review and Meta-Analysis of Factors Affecting Health Technology Assessments in Healthcare

    Jul 1, 2022, 00:00

  • HTA20 A Systematic Review and Statistical Analysis of Factors Influencing the Cost-Effectiveness of Transcatheter Aortic Valve Implantation (TAVI) for Severe Symptomatic Aortic Stenosis

    Jul 1, 2022, 00:00

  • EE135 Cost-Utility Analysis of Benralizumab in Severe Eosinophilic Asthma in Colombia

    Jul 1, 2022, 00:00

  • HSD59 Use of a Discrete Choice Experiment to Quantify Palliative Care Experts Preferences for Optimizing Care Delivery to Patients with Life-Limiting Illnesses

    Jul 1, 2022, 00:00

  • EPH120 Comparing the Effectiveness and Cost-Effectiveness of SARS-COV-2 Screening Strategies Using Rapid Antigen Tests in a Residential College Campus

    Jul 1, 2022, 00:00

  • EPH173 Real Picture of Patients with Charcot-Marie-Tooth Disease in Japan: IQVIA Claims Database

    Jul 1, 2022, 00:00

  • CO84 Cognitive Impairment Among Patients with Alcohol Use Disorders: An Observational Study from South Indian Teaching Hospital

    Jul 1, 2022, 00:00

  • EE146 Cost and Resource Utilization in Friedreich Ataxia: A Systematic Literature Review

    Jul 1, 2022, 00:00

  • EE279 A Systematic Literature Review of the Economic Burden in Patients with Myelodysplastic Syndrome

    Jul 1, 2022, 00:00

  • EPH43 Impact of COVID-19 Pandemic on Cancer Preventive Screening

    Jul 1, 2022, 00:00

  • P40 Cross-Sectional Assessment of Tardive Dyskinesia Work Productivity and Activity Impairment in Patients and Caregivers

    Jul 1, 2022, 00:00

  • EE75 The Economic Value of HPV Multi-Genotype Detection Technology

    Jul 1, 2022, 00:00

  • EPH49 Relationship between Pregnancy-Related Risk Factors and Receipt of Postpartum Care Among Texas Medicaid Enrollees

    Jul 1, 2022, 00:00

  • EE67 The Definition, Economic, and Social Implications of Being "Legally Blind": A Comparison across Countries

    Jul 1, 2022, 00:00

  • CO138 Systematic Review and Meta-Analyses of Longitudinal Studies on Drug Treatments for Gaucher Disease: Focus on Hematological Parameters

    Jul 1, 2022, 00:00

  • EE357 Variations in Comorbidity Burden in Patients with Type 2 Diabetes over Disease Duration and Impacts on Health Care Resource Usage: A Population Based Analysis of Real World Evidence

    Jul 1, 2022, 00:00

  • HTA72 Survival Extrapolation for Immuno-Oncology Drugs: Pessimism or Optimism? a Targeted Literature Review and a Validation-Based Case Study

    Jul 1, 2022, 00:00

  • HPR8 Changes in the Practising Midwives Density per 100 Hospital Beds in European Healthcare Systems

    Jul 1, 2022, 00:00

  • HPR16 Reimbursement Needs Associated with Vaginal Birth and Caesarean-Section in Patients with and without Obesity: Drugs in Chile

    Jul 1, 2022, 00:00

  • EE464 The Cost-Effectiveness of Subcutaneous Semaglutide 2.4MG Injection in the Management of Obesity in Canada Using the Core Obesity Model

    Jul 1, 2022, 00:00

  • P59 Comparative Efficacy and Safety of Ozanimod and Ponesimod for Relapsing Multiple Sclerosis: A Matching-Adjusted Indirect Comparison

    Jul 1, 2022, 00:00

  • HSD69 Stakeholder Perspectives on the Use of Artificial Intelligence in Medicine

    Jul 1, 2022, 00:00

  • HPR2 COVID-19 and the Use of Antenatal Care Services in Côte d'Ivoire, an Africa South of the Sahara's Country

    Jul 1, 2022, 00:00

  • HTA68 Determinants of Funding with Managed Entry Agreements, As Part of Health Technology Assessment Decision-Making Processes: Empirical Evidence from Cancer Therapies in Four Countries

    Jul 1, 2022, 00:00

  • Machine Learning in HEOR

    Jul 1, 2022, 00:00

  • EE323 A Targeted Literature Review of the Cost-Effectiveness of Erythropoiesis-Stimulating Agents As Standard Care for the Treatment of Chemotherapy-Induced Anemia

    Jul 1, 2022, 00:00

  • CO122 Patient Versus Caregiver and Clinician Reports of Cognitive Difficulties in Patients with Schizophrenia Switching to Long-Acting Injectable Antipsychotic Aripiprazole Lauroxil: A Post Hoc Analysis

    Jul 1, 2022, 00:00

  • HSD68 Treatment Intensification in Diabetes: A Perspective from Latin American Guidelines in Patients with an Oral First Line Antidiabetic Drug Regimen

    Jul 1, 2022, 00:00

  • EE2 A Cost-Effectiveness Analysis Comparing Obesity Drug Treatments from a U.S. Payer Perspective

    Jul 1, 2022, 00:00

  • CO129 Pharmacist-Led Medication Review to Reduce Antiretroviral Therapy Errors in HIV/AIDS Patients: A Systematic Review

    Jul 1, 2022, 00:00

  • EE387 Healthcare Resource Utilization in the Treatment of Transfusion-Dependent B-Thalassemia

    Jul 1, 2022, 00:00

  • CO69 Test-Retest Reliability of the PDQ-Exercise

    Jul 1, 2022, 00:00

  • EPH72 Potential Adverse Effects of Passive Immunization Against Respiratory Syncytial Virus (RSV) in Low-Risk Infants in the United States

    Jul 1, 2022, 00:00

  • MSR24 Assessing the Accuracy of a Semi-Markov Model (SMM) with Split Local and Distant Recurrence Health States in Predicting Overall Survival (OS) for Muscle Invasive Urothelial Carcinoma (MIUC)

    Jul 1, 2022, 00:00

  • EE83 A Systematic Review on the Economic Burden of Pneumonia Among Adults Aged 50 and Older

    Jul 1, 2022, 00:00

  • CO82 Racial Disparity Following Surgical Care for Patients Sustaining Gustilo Type III Tibial Fractures Using Propensity-Score Matched Cohorts in a Medicaid Database

    Jul 1, 2022, 00:00

  • EPH56 A Systematic Review on the Global Clinical Burden of Pneumonia Among Adults Aged 50 and Older

    Jul 1, 2022, 00:00

  • CO16 Association between Adherence and Worsening Heart Failure Events in an Employed Population

    Jul 1, 2022, 00:00

  • EPH86 Effect of the COVID-19 Pandemic on the Utilization of Hospice-Palliative Care Services in Hungary

    Jul 1, 2022, 00:00

  • HPR64 What Goes in Must Come Out: An Analysis of NICE Recommendations for Drugs Exiting Managed (Early) Access in England

    Jul 1, 2022, 00:00

  • HPR39 Characterizing US Payer Coverage Policies and Associated Rationale When Those Policies Differ from the Institute for Clinical and Economic Review (ICER) Assessment Determinations

    Jul 1, 2022, 00:00

  • EE411 Healthcare Costs of Direct Oral Anticoagulants Among Medicare Patients with Nonvalvular Atrial Fibrillation and Multimorbidity

    Jul 1, 2022, 00:00

  • CO61 Incremental Healthcare Costs for Cardiac Surgery Patients with New-Onset Post-Operative Atrial Fibrillation

    Jul 1, 2022, 00:00

  • P32 Power Implications of Estimator Choice in Synthetic Control Arm Analyses: Results from a Simulation Comparing Average Treatment Effects on the Treated and Untreated Under Propensity Score Weighting

    Jul 1, 2022, 00:00

  • EE211 Cost of Long COVID Following Severe Disease - a US Healthcare Database Analysis

    Jul 1, 2022, 00:00

  • EE261 Economic Burden of Hemophilia B Patients in the United States: A Systematic Literature Review

    Jul 1, 2022, 00:00

  • MSR15 A Bayesian Approach for Handling Missing Items in Trial-Based Cost-Effectiveness Analysis with Multi-Item Questionnaires

    Jul 1, 2022, 00:00

  • CO62 Evaluating the Clinical Characteristics of Acute Kidney Injury in the ICU Setting

    Jul 1, 2022, 00:00

  • P38 Dupilumab Improves Quality of Life in Caregivers of Children with Uncontrolled Moderate-to-Severe Asthma: Liberty Asthma Voyage Study

    Jul 1, 2022, 00:00

  • EE315 Economic Evaluation of Neutralising Monoclonal Antibodies for the Treatment of COVID-19 Positive People in the Community

    Jul 1, 2022, 00:00

  • EE362 Microcosting of Cataract Surgery Complications from a US Provider Perspective

    Jul 1, 2022, 00:00

  • EE348 Cost-Utility Analysis of Dapagliflozin in Patients with Chronic Kidney Disease in Costa Rica

    Jul 1, 2022, 00:00

  • EE308 Real-World Treatment Patterns and Costs in Relapsed and Refractory Diffuse Large B-Cell Lymphoma in the United States

    Jul 1, 2022, 00:00

  • EE288 A Cost-Effectiveness Analysis of Biologic Compared with Chemical Disease Modifying Drugs in Treating Multiple Sclerosis in US

    Jul 1, 2022, 00:00

  • HTA49 Determining Appropriate Health Economic Modeling Approaches in Fabry Disease

    Jul 1, 2022, 00:00

  • CO90 A Systematic Literature Review of the Clinical Burden in Patients with Myelodysplastic Syndromes

    Jul 1, 2022, 00:00

  • HTA19 The Influence of ICER: Cost-Effectiveness and Decision-Making for USA Payers

    Jul 1, 2022, 00:00

  • CO110 Comparative Effectiveness of Sertraline, Fluoxetine Vs Escitalopram Among Adults with Depression in the United States

    Jul 1, 2022, 00:00

  • EPH71 Uses of Antiepileptic Drugs Among Pregnant Women with Epilepsy in Taiwan, a 15-Year Cohort Study

    Jul 1, 2022, 00:00

  • EPH3 Diabetes and the COVID-19 Epidemic in Algeria: Prevalence and Characteristics of Patients Diagnosed during the First 6 Months of the Epidemic

    Jul 1, 2022, 00:00

  • EE71 Cost-Effectiveness of COVID-19 Vaccination in Colombia: A Micro-Simulation Modelling Analysis

    Jul 1, 2022, 00:00

  • MSR13 Comparison of Three Network Meta-Analysis Methods Based Non-Ph in a Cost-Effectiveness Considering Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma

    Jul 1, 2022, 00:00

  • CO102 Effectiveness of Short Term Neoadjuvant Endocrine Therapy on KI67 in Luminal Breast Cancers

    Jul 1, 2022, 00:00

  • HSD110 JAV-Raras: Comparative Analysis of Patient’s Costs According to Clinical and Therapeutic Protocol (PCDT) and Current Clinical Practice for Osteogenesis Imperfecta (OI) in Brazilian Public Healthcare System

    Jul 1, 2022, 00:00

  • EPH171 Association of Multimorbidity with Use of Health Information Technology

    Jul 1, 2022, 00:00

  • HTA48 Minimum Follow-up Time Required for the Detection of the Impact of Treatments on Neuropathic Pain and Gastrointestinal Complaints in Fabry Disease

    Jul 1, 2022, 00:00

  • HSD63 Real-World Crizanlizumab Treatment Patterns of Patients with Sickle Cell Disease

    Jul 1, 2022, 00:00

  • EE70 CAR-T Treatment Costs Beyond Therapy Acquisition Costs in Multiple Myeloma Patients

    Jul 1, 2022, 00:00

  • EPH79 Projections of Future Health and Economic Burden of Cardiovascular Disease Among Patients with Type 2 Diabetes Mellitus in Australia. Estimates up to 2030

    Jul 1, 2022, 00:00

  • EE84 A Reexamination of Drug Costs for Cetuximab and Panitumimab in Metastatic Colorectal Cancer: Assessing the Influence of Drug Vial Splitting

    Jul 1, 2022, 00:00

  • Cost Effectiveness Analysis in Oncology Studies

    Jul 1, 2022, 00:00

  • EE215 Higher Work Impairment and Increased Healthcare Resource Utilization in Patients with Crohn's Perianal Fistula: Results from a Global Burden of Illness Study

    Jul 1, 2022, 00:00

  • HSD16 Trends in Rheumatology Patient Care and Practice Operations Pre- and Post-COVID-19 Pandemic

    Jul 1, 2022, 00:00

  • EE388 Public Health and Economic Implications of Increasing Access to Herpes Zoster Vaccination Rate in Community Pharmacies

    Jul 1, 2022, 00:00

  • HSD82 Vitiligo: Trends in Real-World Treatment Patterns in the United States

    Jul 1, 2022, 00:00

  • EE416 Real-World Economic Burden of Illicit-Use Opioid Overdose with and without Respiratory Comorbidity in Patients Not on Medication for Opioid Use Disorder

    Jul 1, 2022, 00:00

  • HSD95 Real-World Treatment Patterns and Healthcare Resource Utilization Among Patients Diagnosed with Erythropoietic Protoporphyria and X-Linked Protoporphyria: Results from a US Electronic Medical Records Study

    Jul 1, 2022, 00:00

  • CO12 Development of Frailty Index Using ICD-10 Codes to Predict Mortality and Rehospitalization of Older Adults: An Update of the Multimorbidity Frailty Index

    Jul 1, 2022, 00:00

  • Valuing Child Health Isn’t Child’s Play [Editor's Choice]

    Jul 1, 2022, 00:00

  • EE136 Cost-Effectiveness Analysis of Tisagenlecleucel Using Long-Term Survival Outcomes in Treating Adult Patients with Relapsed or Refractory Large B-Cell Lymphoma from US Societal Perspective

    Jul 1, 2022, 00:00

  • EE364 Cost-Effectiveness of Ferric Carboxymaltose for Treating Iron Deficiency Anemia in China

    Jul 1, 2022, 00:00

  • HSD26 Impact of the COVID-19 Pandemic on Real-World Antipsychotic Treatment Patterns in Patients with Schizophrenia

    Jul 1, 2022, 00:00

  • HSD108 Pharmacist Intention to Provide Palliative Care Services in Saudi Arabia

    Jul 1, 2022, 00:00

  • HTA57 UK Market Access: The Evolving Scope of NICE and NHSE Specialised Commissioning

    Jul 1, 2022, 00:00

  • EE324 Economic Burden of Chronic Kidney Disease in Type 2 Diabetes: A Systematic Review of the Literature

    Jul 1, 2022, 00:00

  • EPH35 Information Seeking and Preventive Behavior during the COVID-19 Pandemic

    Jul 1, 2022, 00:00

  • EPH80 Epidemiological Disease Burden and Cost of Illness of Autism in the US

    Jul 1, 2022, 00:00

  • HTA9 Differences in Guidance on Pro Evidentiary Requirements across Key European HTA Agencies

    Jul 1, 2022, 00:00

  • EPH156 Iron Deficiency Anaemia Among Blood Donors in Algeria: A Cross-Sectional Survey

    Jul 1, 2022, 00:00

  • Editorial Board

    Jul 1, 2022, 00:00

  • CO107 Progression-Free Survival in Patients with Advanced or Metastatic, Hormone Receptor Positive, HER2-Negative Breast Cancer Treated with Palbociclib in Combination with Fulvestrant: A Real-World Study

    Jul 1, 2022, 00:00

  • EE88 Cost-Effectiveness Analysis of Risk Scoring Model in Population-Based Oral Cancer Screening Program of Taiwan

    Jul 1, 2022, 00:00

  • HPR5 Price and Volume Changing Trends of Medicines Based on Index Analysis: An Empirical Case from Shanghai

    Jul 1, 2022, 00:00

  • EE149 Predicting the Population Budget Impact of Current and New Listings for Colorectal Cancer: The PRIMCAT-CRC Model

    Jul 1, 2022, 00:00

  • EE407 Cost-Effectiveness Analysis of Colon and Rectal Cancer Screening Interventions in Beneficiaries of the Instituto Mexicano Del Seguro Social

    Jul 1, 2022, 00:00

  • EE332 A Budget Impact Model for Terlipressin in Treating Bleeding Oesophageal Varices Patients in the Philippines

    Jul 1, 2022, 00:00

  • EE23 Translation, Cross-Cultural Adaptation and Psychometric Testing of a Yoruba Version of the EQ-5D Questionnaire in Patients with Musculoskeletal Disorders

    Jul 1, 2022, 00:00

  • Why Do Adults Value EQ-5D-Y-3L Health States Differently for Themselves Than for Children and Adolescents: A Think-Aloud Study

    Jul 1, 2022, 00:00

  • EE365 Assessment of Hospital Charges for Initial and/or Repeat Catheter Ablations for Atrial Fibrillation Performed in 2017, 2018, or 2019

    Jul 1, 2022, 00:00

  • EE242 Economic Burden Among Chronic Kidney Disease (CKD) Patients with and without Type 2 Diabetes (T2D) in a Commercially Insured/Medicare Advantage (MA) Population in the United States (US)

    Jul 1, 2022, 00:00

  • EE208 Cost-Effectiveness of a Digital Wellness Intervention for Managing Depression and Anxiety: A Payer Perspective

    Jul 1, 2022, 00:00

  • EPH131 Innovative Use of a Large Real-World Database for Identifying Stroke Survivors and Access to Rehabilitation in Primary Care in Brazil

    Jul 1, 2022, 00:00

  • HPR54 International Coverage and Financing Strategies for the Treatment of Obesity: A Scoping Review

    Jul 1, 2022, 00:00

  • EE412 The Journey to Autism Spectrum Disorder Diagnosis: An Examination of Time, Healthcare Utilization, and Costs

    Jul 1, 2022, 00:00

  • EE203 Clinical and Economic Outcomes of Patients with Multiple Rib Fractures Treated Operatively Vs. Non–Operatively — a US Hospital Database Analysis

    Jul 1, 2022, 00:00

  • P43 The Economic Burden of Idiopathic Pulmonary Fibrosis in Australia

    Jul 1, 2022, 00:00

  • CO88 Center-Level Variation in Treatment Satisfaction Questionnaire for Medication (TSQM) Scores in Patients with MS from the Multiple Sclerosis Continuous Quality Improvement (MS-CQI) Research Collaborative Study (2017-2020)

    Jul 1, 2022, 00:00

  • EE140 Estimated Costs for All-Cause Grade 3/4 Adverse Events Among First-Line Tyrosine Kinase Inhibitor Plus Immuno-Oncology-Based Combination Therapies for Patients with Advanced Renal Cell Carcinoma from the United States Perspective

    Jul 1, 2022, 00:00

  • CO121 The Impact of Clinical Trial Participation on Patients with Metastatic Breast Cancer

    Jul 1, 2022, 00:00

  • P27 Addressing Health Barriers Using Social Determinant of Health Data

    Jul 1, 2022, 00:00

  • EE50 Olaparib As Maintenance Therapy for Women with Ovarian Cancer and Homologous Recombination Deficiency in Brazil: What Clinical and Cost Data Have Highest Impact on Cost-Effectiveness Analysis?

    Jul 1, 2022, 00:00

  • HSD103 Prescribing Patterns and Predictors of Opioid Prescription Among Outpatients with Osteoarthritis in the United States

    Jul 1, 2022, 00:00

  • HSD8 Real-World Patient Persisten A Comparison of Prostaglandin Analogs Used for the Treatment of Open-Angle Glaucoma or Ocular Hypertension

    Jul 1, 2022, 00:00

  • EE313 Cost-Effectiveness Analysis of Resmetirom: An Investigational Treatment for the Management of Nonalcoholic Steatohepatitis

    Jul 1, 2022, 00:00

  • EPH126 Association of Depressive Symptoms and Suicidal Ideation with Impulsive Choi Findings from Nationally Representative Survey

    Jul 1, 2022, 00:00

  • EPH81 Statural Growth of at Term Newborns with Intrauterine Growth Retardation: A Prospective Cohort Study in Algeria

    Jul 1, 2022, 00:00

  • CO81 Episode of Care Assurance Program (ECAP) Results in Significantly Reduced Readmissions for Patients Undergoing Primary Total Joint Replacement Surgery

    Jul 1, 2022, 00:00

  • CO75 Predictors of Value-Based Outcomes in Sepsis: An Analysis Using Electronic Health Record and Administrative Claims Data

    Jul 1, 2022, 00:00

  • EPH85 Mortality and Health Care Utilization Trends of Cardiovascular Diseases: Comparing Hungary to OECD Average

    Jul 1, 2022, 00:00

  • EE28 Annual Health Insurance Treatment Cost of Female Infertility of Other Origin Based on Real-World Health Insurance Claims Data

    Jul 1, 2022, 00:00

  • HPR28 Assessment of the French National Experimentation for Incentivising Hospital Prescriptions of Etanercept Biosimilars Delivered in Retail Pharmacies

    Jul 1, 2022, 00:00

  • MSR26 Review of Existing AI-Based Automatic Tools for Evidence Synthesis

    Jul 1, 2022, 00:00

  • EE353 The Economic Burden of Anticholinergic Use in Adults with Overactive Bladder in the United States: A Systematic Literature Review

    Jul 1, 2022, 00:00

  • EE293 Diagnostic Hospitalization and Associated Costs in Patients with Amyloid Light-Chain Amyloidosis

    Jul 1, 2022, 00:00

  • EE418 Burden of Illness Analysis of Fracture Female Patients with Postmenopausal Osteoporosis in China: A Retrospective Electronic Medical Record Database Analysis

    Jul 1, 2022, 00:00

  • EE443 Economic Evaluation of Brexpiprazole As Adjunctive Treatment of Major Depressive Disorder in the Mexican National Health System

    Jul 1, 2022, 00:00

  • HTA7 Cost-Effectiveness Analysis of Nivolumab Plus Chemotherapy Vs Chemotherapy in Patients with Advanced Gastric Cancer in Japan

    Jul 1, 2022, 00:00

  • Disclaimer

    Jul 1, 2022, 00:00

  • EE22 Financial Savings Associated with a Novel Bioprosthetic Engineered to Extend Device Durability Versus Mechanical Aortic Valve Replacements

    Jul 1, 2022, 00:00

  • P46 Missing Data and Missed Opportunities: A Potential Solution to Data Gaps for Societal Perspective Economic Evaluations

    Jul 1, 2022, 00:00

  • EPH67 Comparisons of Twenty-Year Trends in Direct Costs, Absence Payments and Lost Time for Employee "Caregivers” of Patients with Breast, Skin, GI, Female, Male, and "Other” Cancers

    Jul 1, 2022, 00:00

  • EE260 Early Albumin Infusion May Reduce Intensive Care Unit (ICU) Cost in Cirrhotic Patients with Spontaneous Bacterial Peritonitis (SBP): A Cross-Sectional Study

    Jul 1, 2022, 00:00

  • EE243 Economic Evaluation of Lidocaine Patches for the Treatment of Localized Neuropathic Pain from Mexican Public Health System Perspective

    Jul 1, 2022, 00:00

  • Economic Evaluation of Disease Burden Using Real World Data

    Jul 1, 2022, 00:00

  • EPH155 Analysis of the Risk Factors for Failed Back Surgery Syndrome: Real-World Evidence

    Jul 1, 2022, 00:00

  • CO29 Subsidized Screening and Lifestyle Management of Gestational Diabetes Mellitus in Rural China: A Multi-Centre, Randomized Controlled Trial

    Jul 1, 2022, 00:00

  • EE100 Treatment-Related Lost Productivity in Paroxysmal Nocturnal Hemoglobinuria: A Comparison of Investigational Subcutaneous Ravulizumab and Pegcetacoplan in the United States

    Jul 1, 2022, 00:00

  • HPR44 HTA in the Private Health Insurance Sector in Brazil: Document Analysis

    Jul 1, 2022, 00:00

  • HTA41 Consequences of Brexit: Medicines Access to Northern Ireland

    Jul 1, 2022, 00:00

  • EE178 CEA of Once-Weekly Subcutaneous Semaglutide Versus Dulaglutide in Patients with Type 2 Diabetes with Inadequate Glycemic Control in China

    Jul 1, 2022, 00:00

  • EPH164 Illness Severity Associated with Comorbid Substance Use Disorders in Schizophrenia: An Electronic Health Record Study

    Jul 1, 2022, 00:00

  • EPH118 Incidence of Human Papillomavirus (HPV)-Related Cancers before and after HPV Vaccine Introduction Among Males and Females 15-44 Years Old in the US

    Jul 1, 2022, 00:00

  • HSD88 Fruit and Vegetable Consumption in Hungary during the Fall of COVID-19 Pandemic in 2020

    Jul 1, 2022, 00:00

  • P2 Faster Access to Innovative Therapies with Risk-Sharing Agreements - Cancer Medication Reimbursement Decisions from January 2012 to November 2021 in Finland

    Jul 1, 2022, 00:00

  • P58 Measuring the Real-World Impact of Subsidy Decision on Clinical Practice and Patient Outcomes: Post-Subsidy Evaluation of Sofosbuvir/Velpatasvir for Treating Chronic Hepatitis C

    Jul 1, 2022, 00:00

  • EPH5 Prevalence of Hematuria and Its Association with Urinary Tract Cancer: A Case-Control Study Using Real-World Data from UK Primary Care

    Jul 1, 2022, 00:00

  • CO77 Efficacy of PD1/PD-L1 Inhibitors VS Chemotherapy As First-Line Treatment of Non-Small Cell Lung Cancer Among Patients with Different PD-L1 Expression Levels

    Jul 1, 2022, 00:00

  • HSD92 Natural Language Processing (NLP) of Unstructured EMR Data to Describe Treatment Patterns and Achievement of Guideline Recommended LDL-C Targets of Canadian Patients with Ascvd and Hypercholesterolemia

    Jul 1, 2022, 00:00

  • EE106 Evaluation of Full Factorial and Latin Hypercube Sampling As Alternatives to Traditional Random Selection for Probabilistic Uncertainty Analyses

    Jul 1, 2022, 00:00

  • EPH74 Epidemiological Disease Burden and Cost of Illness of Systemic Lupus Erythematosus (SLE) in the US

    Jul 1, 2022, 00:00

  • EE252 Costing Analysis of Early Childhood Development Project of the Integrated Maternal and Child Health and Development Programme (2017-2020)

    Jul 1, 2022, 00:00

  • EE445 Annual Health Insurance Treatment Cost of Polycystic Ovary Syndrome Based on Real-World Health Insurance Claims Data

    Jul 1, 2022, 00:00

  • HSD67 The Burden of Systemic Glucocorticoid (GC) Use in Anti-Neutrophilic Cytoplasmic Autoantibody (ANCA)-Associated Vasculitis Patients

    Jul 1, 2022, 00:00

  • HSD100 HER2 and Other Biomarker Testing Patterns Among Patients with Advanced Gastric Cancer (GC) or Gastric Esophageal Junction Cancer (GEJC)

    Jul 1, 2022, 00:00

  • EE497 Real-World Healthcare Resource Utilization and Associated Costs in Patients with Eosinophilic Esophagitis

    Jul 1, 2022, 00:00

  • EE190 Cost-Effectiveness of Dapagliflozin Alone or in Combination with Saxagliptin Added to Standard of Care for the Management of Diabetic Kidney Disease in the United States

    Jul 1, 2022, 00:00

  • EE99 Economic Burden of COVID-19 in Mexico

    Jul 1, 2022, 00:00

  • Studies on COVID-19 Healthcare Impacts

    Jul 1, 2022, 00:00

  • CO43 Identifying Co-Morbidity, Outcomes, Hospital Utilization, and Racial Differences in Patients Ages 18-64 with Colorectal Cancer That Were Hospitalized between 2016 and 2019

    Jul 1, 2022, 00:00

  • HSD112 Uptake of Newer Second-Line Diabetes Medications in Real-World Vulnerable Populations

    Jul 1, 2022, 00:00

  • EE143 Cost-Effectiveness of Belantamab Mafodotin (BELAMAF) VS. Melphalan Flufenamide in Combination with Dexamethasone (MEL+DEX) in Heavily PRE-Treated Relapsed/Refractory Multiple Myeloma Patients: A U.S. Payer Perspective

    Jul 1, 2022, 00:00

  • EE336 Budget Impact Analysis of Nefecon for the Treatment of Primary IgA Nephropathy in the United States

    Jul 1, 2022, 00:00

  • Epidemiology Public Health

    Jul 1, 2022, 00:00

  • EPH76 Prevalence and Predictors of Prediabetes in a Multiethnic Society

    Jul 1, 2022, 00:00

  • MSR7 Evaluating the Impact of Weighted Sample Size on Matching Adjusted Indirect Treatment Comparisons between Trials with Time-to-Event Outcome: A Simulation Study

    Jul 1, 2022, 00:00

  • HPR38 Drug Spending and Medication Use after Implementing a Formulary That Incorporates Formal Value Assessment

    Jul 1, 2022, 00:00

  • EE97 Population Discordance in Economic Evaluations of Polygenic Risk Scores

    Jul 1, 2022, 00:00

  • CO137 Real-World Outcomes Associated with Bezlotoxumab Use Among Medicare Beneficiaries with Clostridioides Difficile Infection

    Jul 1, 2022, 00:00

  • CO79 Predictors of Outcomes Measured after Loss of Ambulation in Duchenne Muscular Dystrophy: A Literature Review and Grading of the Evidence

    Jul 1, 2022, 00:00

  • HTA70 Forecasting Drug Price for Reimbursement By Utilizing a Value-Price Relationship, a Case Study in Hormone-Relapsed Prostate Cancer

    Jul 1, 2022, 00:00

  • EE309 Pharmacoeconomic and Pharmacoepidemiological Analysis of the Use of Drugs in an Anti-Tuberculosis Hospital Based on the Local Real-World Data

    Jul 1, 2022, 00:00

  • HPR22 Copayment for Prescription Drugs Under Taiwan's National Health Insuran A Cross-Sectional Study, 2008-2017

    Jul 1, 2022, 00:00

  • EPH159 Burden of Ischemic Heart Disease in Colombia: A Simulation from a Live-Birth Cohort

    Jul 1, 2022, 00:00

  • EE241 Clinical Pharmacist Dosage-Adjustment Interventions in Egyptian Hospitals: Do They Save Costs?

    Jul 1, 2022, 00:00

  • EPH109 A Scoping Review of Interactive Online Decision Tools to Guide Surgery and Adjuvant Treatment Decisions in Breast Cancer

    Jul 1, 2022, 00:00

  • EE316 End-of-Life Costs in Multiple Sclerosis: An Analysis of Medicare Claims Data

    Jul 1, 2022, 00:00

  • EE144 Real-World Economic Evaluation of Prospective Rapid Whole-Genome Sequencing Compared to a Matched Retrospective Cohort of Critically Ill Pediatric Patients in the United States

    Jul 1, 2022, 00:00

  • HSD41 2015 American Thyroid Association Guidelines and Outcomes for Patients with Thyroid Cancer

    Jul 1, 2022, 00:00

  • HPR37 Achieving Better Birth Outcomes Among Black Women: A Linked EMR/Claims Analysis of Visit History and Outcomes

    Jul 1, 2022, 00:00

  • HTA35 Testing and Piloting of a Value Framework for Diagnostic Technologies in Latin America

    Jul 1, 2022, 00:00

  • HTA17 An Algorithmic Theory of Value-Based Price Adjustment Using Incremental Cost-Effectiveness Ratio: Regarding a Real-World Case in Japan

    Jul 1, 2022, 00:00

  • EPH61 Comparing Fibrosis Staging Approaches Among Patients with Non-Alcoholic Steatohepatitis (NASH) Using Real World Data (RWD)

    Jul 1, 2022, 00:00

  • EPH157 The Impact of BRAF V600E Mutation and Microsatellite Instability on Overall Survival (OS) in Metastatic Colorectal Cancer (MCRC)

    Jul 1, 2022, 00:00

  • EE264 Productivity Loss Due to Hematologic Malignancies-Related Premature Mortality in Brazil between 2001 and 2030

    Jul 1, 2022, 00:00

  • EE96 Using Multi-State Modelling for Health Economic Evaluations

    Jul 1, 2022, 00:00

  • HTA24 Orphan Drugs: What Is the Impact of Special Provisions in Value Assessment?

    Jul 1, 2022, 00:00

  • EPH150 Epidemiological Disease Burden of Female Infertility Associated with Anovulation Based on Real-World Health Insurance Claims Data

    Jul 1, 2022, 00:00

  • EE72 The Relative Value of Anti-Obesity Medications Compared to Similar Therapies

    Jul 1, 2022, 00:00

  • HSD17 Relationship between BMI and Healthcare Costs in a Commercial and Medicare Population

    Jul 1, 2022, 00:00

  • EE246 Cost-Effectiveness of OC/Lep Intervention for Treatment of Dysmenorrhea and Endometriosis in Japan

    Jul 1, 2022, 00:00

  • P15 Drivers of Health Disparities and Consequences for COVID-19 Vaccine Choices: Modelling Health Preference Heterogeneity Among Underserved Populations

    Jul 1, 2022, 00:00

  • EE498 Economic Burden of Interstitial Lung Disease in a Commercially Insured Population with Sjogren's Syndrome in the United States

    Jul 1, 2022, 00:00

  • EPH107 An Evaluation of the Relationship between QTc Prolonging Medications, Tisdale Risk Scores and Mortality Using a Nationally Representative Electronic Health Records Database

    Jul 1, 2022, 00:00

  • EPH149 Knowledge of Human Papillomavirus Among Women Aged between 25-65 YEARS in Hungary

    Jul 1, 2022, 00:00

  • P51 Osteoarthritis Affecting Health-Related Quality of Life Among Older Patients

    Jul 1, 2022, 00:00

  • EE434 Cost savings and cost avoidance with the inpatient clinical pharmacist interventions in a tertiary cancer

    Jul 1, 2022, 00:00

  • EPH93 Treatment Patterns of Triple Negative Breast Cancer in Brazilian Private Healthcare Setting: a Claim Database Study

    Jul 1, 2022, 00:00

  • EE408 The Effect of Medical Innovation on the Cost-Effectiveness of COVID 19-Related Policies in the United States Using a Sir Model

    Jul 1, 2022, 00:00

  • EE474 Cost-Effectiveness Model for a Novel Functional ASSAY Versus Provider Selection of Third-Line Treatment of Patients with Refractory Metastatic Colorectal Cancer

    Jul 1, 2022, 00:00

  • HSD93 Trends in the Use of Biologics for Treatment of Psoriatic Arthritis

    Jul 1, 2022, 00:00

  • HPR15 Cause and Cure: Weighing the Prospective Impact of Cures 2.0 ACT Breakthrough Device Coverage on a Linked US Regulatory and Payer Framework

    Jul 1, 2022, 00:00

  • The (Harsh) Reality of Real-World Data External Comparators for Health Technology Assessment

    Jul 1, 2022, 00:00

  • EE372 Cost-Utility of Ribociclib As the First-Line Treatment in Postmenopausal Women with Hormone Receptor Positive and Human Epidermal Growth Factor Receptor-2 Negative Advanced/Metastatic Breast Cancer in Colombia

    Jul 1, 2022, 00:00

  • MSR4 Implications of Cure Fractions on Costs of Cancer Care: An Innovative Application to Multi-Cancer Early Detection (MCED) Economic Modeling

    Jul 1, 2022, 00:00

  • CO85 Medication and Education Compliance in Type II Diabetes

    Jul 1, 2022, 00:00

  • Table of Contents

    Jul 1, 2022, 00:00

  • EE123 Budget Impact Analysis of Sacral Neuromodulation in Fecal Incontinence in Obras Sociales and Empresas De Medicina Prepaga in Argentina

    Jul 1, 2022, 00:00

  • CO105 Does Preoperative Chest Physiotherapy Affect the Postoperative Pulmonary Complications and Lung Functions in Patients Undergoing Elective Cardiac Surgery? a Systematic Review and Meta-Analysis

    Jul 1, 2022, 00:00

  • EE462 Value-Based Pricing for Patent-Protected Medicines: Pricing Anomalies in the "Age of Cures” and Their Implications for Dynamic Efficiency

    Jul 1, 2022, 00:00

  • EE160 Tepotinib for the Treatment of Adult Patients with Metastatic Non-Small Cell Lung Cancer Harboring METEX14 Skipping Alterations: A US Cost-Effectiveness Analysis

    Jul 1, 2022, 00:00

  • EE206 Cost of Neuromyelitis Optica Spectrum Disorder Misdiagnosis

    Jul 1, 2022, 00:00

  • HTA74 Could Artificial Intelligence Support Prediction of Reimbursement Decisions in Scotland? A Pilot Project

    Jul 1, 2022, 00:00

  • EE127 Economic Impact of Balloon Guide Catheter Use with Mechanical Thrombectomy for Acute Ischemic Stroke: A U.S. Payer Perspective Cost Analysis

    Jul 1, 2022, 00:00

  • EE8 Cost-Effectiveness and Cost-Utility of a Digital Wellness Intervention for Managing Depression and Anxiety: An Employer Perspective

    Jul 1, 2022, 00:00

  • MSR44 A Machine Learning Aided Systematic Review of Screen Media Use and Executive Functions Among Children and Adolescents

    Jul 1, 2022, 00:00

  • EE415 Spatial Cost-Efficiency Analysis on the Separability Condition of COVID-19 Potential Determinants

    Jul 1, 2022, 00:00

  • MSR47 Feasibility Assessment of Indirect Treatment Comparison of Biologics for Treating Chronic Rhinosinusitis with Nasal Polyps

    Jul 1, 2022, 00:00

  • HTA56 COVID-19 from the Perspective of Intellectual Property

    Jul 1, 2022, 00:00

  • HSD89 Impact of Race on Utilization of First Vs Second Generation Long-Acting Injectable Antipsychotics Among Medicaid Beneficiaries with Schizophrenia

    Jul 1, 2022, 00:00

  • HSD32 Using Natural Language Processing (NLP) of Unstructured EMR Data to Describe Canadian Patients with Familial Hypercholesterolemia (FH) and Their Management

    Jul 1, 2022, 00:00

  • EE139 Using a User-Friendly Modeling Tool to Inform and Guide Local Decision-Making for Lynch Syndrome Screening at Healthcare Systems

    Jul 1, 2022, 00:00

  • CO156 Systematic Literature Review of the Efficacy and Safety of Infigratinib for the Treatment of Advanced Cholangiocarcinoma

    Jul 1, 2022, 00:00

  • MSR21 Cost-Effectiveness Analysis of Treatments for Nonsense Mutation Duchenne Muscular Dystrophy: Expert Validation of Model Face Validity

    Jul 1, 2022, 00:00

  • EPH32 Perceived Risk of COVID-19 and Its Association with Preparedness and Preventive Practices: A Latent Class Segmentation Analysis

    Jul 1, 2022, 00:00

  • EPH53 Epidemiological Disease Burden of Unspecified Female Infertility Based on Real-World Health Insurance Claims Data

    Jul 1, 2022, 00:00

  • EE20 An Overview of Optimisation Studies on COVID-19 and Its Economic Benefits in India

    Jul 1, 2022, 00:00

  • HPR47 Impact of Zero-Dollar Copayment and Premium Changes on Medication Adherence in Diabetic Patients in an Employee Health Group

    Jul 1, 2022, 00:00

  • EPH94 Prevalence and Factors Associated with Complementary and Alternative Medicine (CAM) and Prescription Drugs Use in Adults with Inflammatory Chronic Conditions (ICC)

    Jul 1, 2022, 00:00

  • EE158 Budget Impact of LYBALVI® for the Treatment of Schizophrenia and Bipolar I Disorder from a US Payer Perspective

    Jul 1, 2022, 00:00

  • CO25 Effects of Pharmacist Interventions on Pain Intensity: Systematic Review and Meta-Analysis of Randomized Controlled Trials

    Jul 1, 2022, 00:00

  • EPH58 The Experiences of Healthcare Workers during the Second Wave of COVID-19 Crisis in the South Indian State of Kerala

    Jul 1, 2022, 00:00

  • EE34 Comparing the Cost-Effectiveness of the Otago Exercise Programme Among Older Women and Men: A Secondary Analysis of a Randomized Controlled Trial

    Jul 1, 2022, 00:00

  • EE157 National Implementation of a Lifestyle Intervention to Reduce Gestational Weight Gain Provides Large Returns on Investment: A Budget Impact Analysis for Australia

    Jul 1, 2022, 00:00

  • P70 Evaluation of Cost and Health Utilization Outcomes of Medicare Beneficiaries Enrolled in a Medication Synchronization Program

    Jul 1, 2022, 00:00

  • EPH6 Health-Related Quality of Life (HRQOL) Among Chinese Population during the COVID-19 Pandemic: The Role of Socio-Demographic Factors and Loneliness

    Jul 1, 2022, 00:00

  • HTA3 Passport for Travel: Proposed Framework for Transportability of Oncology Real World Evidence

    Jul 1, 2022, 00:00

  • HSD86 Association between Medicare Beneficiaries’ Perceptions of Their Physicians and Discussion of Urinary Incontinence

    Jul 1, 2022, 00:00

  • EE201 Cost-Effectiveness of Romiplostim for the Treatment of Patients with Early Immune Thrombocytopenia in the Czech Republic

    Jul 1, 2022, 00:00

  • HSD117 Sociodemographic Disparities in COVID-19 Vaccinations Still Exist 1 Year Following Vaccine Rollout

    Jul 1, 2022, 00:00

  • HSD119 Persistence to Treatment with Initially Prescribed Antiplatelet Agents for the Onset of Acute Coronary Syndrome

    Jul 1, 2022, 00:00

  • P31 Feasibility of Using Oncology Specific Electronic Health Records (EHR) Data to Emulate Clinical Trial Inclusion and Exclusion Criteria

    Jul 1, 2022, 00:00

  • Economic Evaluation

    Jul 1, 2022, 00:00

  • EE238 Healthcare Costs of COVID-19 Versus Flu and Pneumonia - a Payer Perspective

    Jul 1, 2022, 00:00

  • MSR36 Developing the Consolidated Health Outcomes/Interventions Choice-Modeling Evaluation Standards (CHOICES): A Content Analysis

    Jul 1, 2022, 00:00

  • Health Technology Assessment

    Jul 1, 2022, 00:00

  • EE352 Projecting the Incidence and Costs of Major Cardiorenal Complications of Type 2 Diabetes with Widespread GLP-1 RA and SGLT2I Use

    Jul 1, 2022, 00:00

  • Methods for Early Assessment of the Societal Value of Health Technologies: A Scoping Review and Proposal for Classification [Editor's Choice]

    Jul 1, 2022, 00:00

  • CO26 Efficacy and Safety of First-Line Treatments for Patients with Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: A Systematic Review and Indirect Treatment Comparison

    Jul 1, 2022, 00:00

  • CO70 Change in KI-67 Index in Patients Receiving Preoperative Endocrine Therapy Among Hormone Positive Breast Cancer Patients: A Systematic Review and Meta-Analysis

    Jul 1, 2022, 00:00

  • EPH30 Economic Burden of Adverse Events Associated with Erythropoiesis-Stimulating Agents for the Treatment of Anemia Among Chronic Kidney Disease Patients in Taiwan

    Jul 1, 2022, 00:00

  • HPR61 Impact of an Imatinib Volume-Based Purchase Policy (VBP) on the Use of Tyrosine Kinase Inhibitors (TKI) for Chronic Myeloid Leukemia (CML) in Chinese Tertiary Care Hospitals: A Retrospective Analysis

    Jul 1, 2022, 00:00

  • HSD104 Antibiotics Dispensed at Drugstores for Mild Cases of COVID-19 Patients in Northern Punjab, Pakistan

    Jul 1, 2022, 00:00

  • HTA55 Use of Surrogate Endpoints for Obtaining Accelerated Approval - a Market-Level Descriptive Analysis

    Jul 1, 2022, 00:00

  • P64 Cost-Utility Analysis Comparing Mastectomy and Lumpectomy in Early Stage Breast Cancer Surgeries in Sweden - a Life-Time Approach Using Markov Modelling

    Jul 1, 2022, 00:00

  • EPH52 Cause-Specific Mortality Among Patients with Hemophilia: A Systematic Review and Meta-Analysis

    Jul 1, 2022, 00:00

  • EE470 Cost-Effectiveness Analysis of the TCM “Yupingfeng Granules” in the Treatment of Acute Exacerbations of COPD Based on a Randomized Clinical Trial

    Jul 1, 2022, 00:00

  • EE212 Cost-Effectiveness of Pneumococcal Vaccination Implementation in Older Adult Immunization Schedule in the Brazilian National Program

    Jul 1, 2022, 00:00

  • P26 Unintended Consequences of the CDC’s 2016 Guideline for Prescribing Opioids for Chronic Pain for the Individuals with Sickle Cell Disease

    Jul 1, 2022, 00:00

  • HSD3 Choosing Wisely? Use of Intensity Modulated Radiation Therapy Following Lumpectomy in Early-Stage Breast Cancer: A Seer-Medicare Analysis

    Jul 1, 2022, 00:00

  • EPH127 Systematic Literature Review of the Humanistic and Economic Impact of Angelman Syndrome

    Jul 1, 2022, 00:00

  • HSD64 The Influence of COVID-19 on Telemedicine Services Among Blue Cross and Blue Shield of Louisiana Members with Diabetes

    Jul 1, 2022, 00:00

  • EPH162 Persistent Social Gradient in Immunization Coverage By Wealth Quintile in Ethiopia

    Jul 1, 2022, 00:00

  • EE131 Health-Economic Evaluation of Early Screening for Individuals Younger Than Age 50 with Familial Colorectal Cancer Risk Based on a Decision Analysis within the Farkor Study

    Jul 1, 2022, 00:00

  • EPH78 Beliefs Regarding HPV Vaccination Among Young Adult College Students: A Qualitative Study

    Jul 1, 2022, 00:00

  • HPR66 Cost Savings Associated with One-Stage vs Two-Stage Spinal Cord Stimulation from Medicare Perspective

    Jul 1, 2022, 00:00

  • EPH26 Feasibility of Identifying Alopecia Areata Cases in an Atopic Dermatitis Population

    Jul 1, 2022, 00:00

  • HPR55 How Inequities and Disparities in Health Healthcare Are Impacting COVID-19 Outcomes: A Scoping Review

    Jul 1, 2022, 00:00

  • EE29 Annual Health Insurance Treatment Cost of Female Infertility Associated with Male Factors Based on Real-World Health Insurance Claims Data

    Jul 1, 2022, 00:00

  • EPH165 Comparisons of Twenty-Year Trends in Direct Costs, Absence Payments and Lost Time for Employees with Breast, Skin, GI, Female, Male, and "Other” Cancers

    Jul 1, 2022, 00:00

  • EE19 A Retrospective US Claims Database Analysis of the Impact of Fremanezumab on Migraine-Related Health Care Utilization and Costs in Patients with Potential Acute Medication Overuse

    Jul 1, 2022, 00:00

  • EE105 Triamcinolone Acetonide Injectable Suspension, for Suprachoroidal Use, for the Treatment of Macular Edema Associated with Uveitis in the United States: A Budget Impact Analysis

    Jul 1, 2022, 00:00

  • Evidence on Treatment Access, Disparities and Social Determinants of Health

    Jul 1, 2022, 00:00

  • HSD61 Trends in Utilization and Costs for Migraine Prophylaxis and Treatment in the United States, 2017-2020

    Jul 1, 2022, 00:00

  • P52 Mapping CHU9D Utility Scores from the PEDSQLTM for Children with Chronic Conditions in an Ethnically Diverse and Deprived Metropolitan Population

    Jul 1, 2022, 00:00

  • EPH11 Mortality and Health Care Utilization Trends of Diabetes Mellitus: Comparing Hungary to OECD Average

    Jul 1, 2022, 00:00

  • MSR18 The Effect of Weight Loss on Hypothalamus Structure and Function in Obese Individuals: A Systematic Literature Review and Meta-Analysis

    Jul 1, 2022, 00:00

  • EE403 Cost-Effectiveness Analysis of Nivolumab Compared to Pembrolizumab in Previously Untreated Locally Advanced or Metastatic Non-Small Cell Lung Cancer Patients

    Jul 1, 2022, 00:00

  • EE406 Households Direct Economic Burden Associated with Chronic Non-Communicable Diseases in Saudi Arabia

    Jul 1, 2022, 00:00

  • EE269 Long-Term Cost-Effectiveness of a Pharmacist-Led Medication Therapy Management Clinic (MTMC) for Type 2 Diabetes Management

    Jul 1, 2022, 00:00

  • EE458 Health Care Resource Utilization and Costs of CAR T-Cell Therapy in Patients with Diffuse Large B-Cell Lymphoma: A Retrospective Claims Database Analysis in the US

    Jul 1, 2022, 00:00

  • MSR17 Logical Soundness in a Discrete Choice Experiment Study of Benefit Risk Preferences

    Jul 1, 2022, 00:00

  • CO20 Costs Analysis, Effectiveness and Safety Associated with Chimeric Antigen Receptor (CAR)-T Cell Therapy: Results from a Portuguese Comprehensive Cancer Center

    Jul 1, 2022, 00:00

  • CO141 The Impact of Operative Approach on Postoperative Outcomes and Healthcare Cost Following Lobectomy for Lung Cancer Patients in Japan

    Jul 1, 2022, 00:00

  • HSD13 Factors Associated with Prescribing of Teriflunomide and Dimethyl Fumarate Versus Fingolimod in Multiple Sclerosis

    Jul 1, 2022, 00:00

  • CO154 Ramucirumab+Docetaxel Post Immune Checkpoint Inhibitors (ICIS) and Platinum-Based Chemotherapy (CHEMO) in Advanced or Metastatic Non-Small Cell Lung Cancer (ANSCLC): Learnings from the Treat-Lung Observational Study

    Jul 1, 2022, 00:00

  • CO6 Clinical and Economic Outcomes of Adult Limb Spasticity Treatment with Botulinum Toxin-a (BONT-A) Products: A Single-Center Non-Interventional Retrospective Study

    Jul 1, 2022, 00:00

  • EPH17 A Comprehensive Whole Disease Model: Targeted Literature Review and Feasibility Assessment in Schizophrenia

    Jul 1, 2022, 00:00

  • EE277 Cost-Effectiveness Analysis of National Smoking Cessation Service Among Chronic Obstructive Pulmonary Disease (COPD) Patients in Thailand

    Jul 1, 2022, 00:00

  • CO42 Major Clinical Manifestations and Events Among Patients with Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) in the United States: Real-World Results from LC-FAOD Odyssey

    Jul 1, 2022, 00:00

  • P74 Real-World Comparative Effectiveness of Pegfilgrastim Biosimilars Versus Originator

    Jul 1, 2022, 00:00

  • EE333 Analysis of the Cost of Managing Patients with Advanced or Metastatic Non-Small Cell Lung Cancer in Argentina: Lorlatinib VS Alectinib

    Jul 1, 2022, 00:00

  • CO73 Association of Antipsychotic Treatment Adherence and Switching with Healthcare Utilization Using Medical Records Data

    Jul 1, 2022, 00:00

  • CO103 Length of Stay, Cost, and Outcomes Related to Traumatic Subdural Hematoma in Inpatient Setting in the United States

    Jul 1, 2022, 00:00

  • EE433 A US Claims Database Analysis of the Impact of Fremanezumab on Migraine-Related Health Care Utilization and Costs in Patients with Common Comorbidities, Acute Medication Overuse, or Difficult-to-Treat Migraine

    Jul 1, 2022, 00:00

  • Economic Evaluation

    Jul 1, 2022, 00:00

  • EE196 Healthcare Resource Use Among Patients Treated with Lurasidone or Cariprazine for Depressive Episodes Associated with Bipolar I Disorder

    Jul 1, 2022, 00:00

  • EE317 Real-World Economic Benefit of Naloxone Use Among Illicit-Use Opioid Overdose Patients and Respiratory Comorbidity on Medication for Opioid Use Disorder (MOUD)

    Jul 1, 2022, 00:00

  • EE234 Advantages of Visualizing Net Loss Curves in Cost Effectiveness Analyses: An Example Comparing Opioid Use Disorder Treatment Alternatives

    Jul 1, 2022, 00:00

  • MSR41 Matching-Adjusted Indirect Comparison of Amivantamab Vs. Mobocertinib in EGFR Exon 20 Insertion-Mutated Non-Small Cell Lung Cancer

    Jul 1, 2022, 00:00

  • EE419 Cost-Effectiveness Analysis of Non-Invasive Screening in Patients with Diabetic Foot Ulcers

    Jul 1, 2022, 00:00

  • EPH90 Evolution of the Prevalence of Polypharmacy in a Poor Population of the Colombian Caribbean during 2019-2021

    Jul 1, 2022, 00:00

  • EE440 Economic Evaluation of Nefecon in Primary IgA Nephropathy in The United States

    Jul 1, 2022, 00:00

  • EE346 Real-World Health Insurance Treatment Cost of Endometriosis in Hungary in 2019: A Cost of Illness Study

    Jul 1, 2022, 00:00

  • CO93 Powered Stapling System with Gripping Surface Technology for Pulmonary Resection of Lung Cancer: A Propensity-Score Matched Study

    Jul 1, 2022, 00:00

  • EE482 Cost-Effectiveness Analysis of Once-Weekly Semaglutide for the Treatment of Patients with Type 2 Diabetes in Mexico

    Jul 1, 2022, 00:00

  • HTA53 Combination Therapies: Two Is Company but Is Three (OR MORE) a Concern?

    Jul 1, 2022, 00:00

  • HPR40 List Prices for Medicare Negotiation-Eligible Medicines Targeted By Build Back Better Drug Pricing Provisions Estimated to be Reduced By over 40% on Average

    Jul 1, 2022, 00:00

  • EE124 Return to Work Following Rotator Cuff Repair Surgery in the U.S.

    Jul 1, 2022, 00:00

  • EE345 Health Insurance Treatment Cost of Female Infertility of Tubal Origin Based on Real-World Health Insurance Claims Data in 2019

    Jul 1, 2022, 00:00

  • EE166 Cost-Effectiveness of Treatment Strategies for Severe Hemophilia a Patients in the United States

    Jul 1, 2022, 00:00

  • EE299 Budget Impact Analysis of Sentinel Prostate Test Versus Current Diagnostic Strategy for Men with Suspicion of Prostate Cancer in the US

    Jul 1, 2022, 00:00

  • EE266 Integrating Royston-Parmar Flexible Parametric Survival Models for Time Dependent Hazard Rates into Microsoft Excel for Health Economic Modelling

    Jul 1, 2022, 00:00

  • P4 What Can the US Learn from Regulatory Decisions and Health Technology Assessments of New Drugs in Other Countries?

    Jul 1, 2022, 00:00

  • EE227 Systematic Review on Cost-Effectiveness of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists

    Jul 1, 2022, 00:00

  • HPR26 Pricing, Reimbursement and Market Access Trends for Cell and Gene Therapies in the US and Europe

    Jul 1, 2022, 00:00

  • EE189 CAPOX versus mFOLFOX as Adjuvant Chemotherapy in Patients with Stage 3 Colon Cancer: A Cost-Effectiveness Study

    Jul 1, 2022, 00:00

  • HSD130 Utilization and Factors Associated with the Use of Alternative Pembrolizumab Dosing Regimens in Real-World: A US-Based EMR Study

    Jul 1, 2022, 00:00

  • EE422 Healthcare Costs Associated with Severe VS Moderate and Mild COVID-19 - a US Payer Perspective

    Jul 1, 2022, 00:00

  • EE197 Cost-Effectiveness Analysis of Trastuzumab Emtansine Versus Pertuzumab with Trastuzumab for Chinese Patients with Residual Invasive HER2-Positive Early Breast Cancer

    Jul 1, 2022, 00:00

  • HTA47 Recommendations on Best Practices for Rwd Study Design to Support HTA Decision Process in Europe

    Jul 1, 2022, 00:00

  • Reviewer Acknowledgment

    Jul 1, 2022, 00:00

  • EE305 Economic Burden in Adult Patients with Small Cell Lung Cancer (SCLC) Receiving Second-Line Therapy: A Systematic Literature Review (SLR)

    Jul 1, 2022, 00:00

  • Affordability and Value in Decision Rules for Cost-Effectiveness: A Survey of Health Economists

    Jul 1, 2022, 00:00

  • EE486 A Cost-Effectiveness Analysis of Azithromycin for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease

    Jul 1, 2022, 00:00

  • EE479 Cost-Effectiveness of Olaparib Compared to Rucaparib for the Treatment of Metastatic Castration-Resistant Prostate Cancer (MCRPC) in United States

    Jul 1, 2022, 00:00

  • EE24 The Cost-Effectiveness of Atidarsagene Autotemcel for the Treatment of Metachromatic Leukodystrophy (MLD) in France

    Jul 1, 2022, 00:00

  • MSR43 Extracting Severity Markers from Unstructured Clinical Data of Congestive Heart Failure Patients Using a Pretrained Text-to-Text Transfer Transformer Model

    Jul 1, 2022, 00:00

  • EPH7 Racial Disparities in Colorectal Cancer Outcomes: How Community Health Workers Can Increase Screening Uptake in the US

    Jul 1, 2022, 00:00

  • HSD23 Using Natural Language Processing of Unstructured EMR Data to Describe Canadian Patients with ASCVD

    Jul 1, 2022, 00:00

  • EE451 Healthcare Resource Use, Concomitant Conditions, and Treatment Patterns in Huntington's Disease: A Commercial Claims Analysis

    Jul 1, 2022, 00:00

  • HPR17 Racial and Ethnic Disparities in Multiple Myeloma: Moving Towards Inclusion or at a Standstill?

    Jul 1, 2022, 00:00

  • EE401 Productivity Loss and Indirect Costs Associated with Migraine and Probable Migraine in Korea

    Jul 1, 2022, 00:00

  • CO120 Patients With Chronic Migraine Improving to Fewer than 4 Monthly Headache Days Is an Effective Treatment Goal for Chronic Migraine

    Jul 1, 2022, 00:00

  • EPH88 Epidemiological Disease Burden of Ovarian Endometriosis Based on Real-World Health Insurance Claims Data

    Jul 1, 2022, 00:00

  • EE361 Preliminary Cost-Effectiveness Analysis of Proton Beam Therapy in Patients with Hepatocellular Carcinoma in Japan

    Jul 1, 2022, 00:00

  • EE489 Cost-Effectiveness of 3-Antigen Vs. Single-Antigen Vaccine for Prevention of Hepatitis B in Adults in the United States

    Jul 1, 2022, 00:00

  • CO108 Subgroup Analysis of Quality of Life and Treatment Satisfaction By Disease Duration and Use of PRIOR Treatment: Pooled Results from Two Randomized Phase 3 Studies of Ruxolitinib Cream for the Treatment of Vitiligo

    Jul 1, 2022, 00:00
  • «
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40 (current)
  • »